Organization
Institut de Cancérologie de l'Ouest (ICO)-site René Gauducheau
1 abstract
Abstract
Effect of dual properties of regorafenib in osteosarcoma on tumor progression and bone parameters in mouse preclinical models.Org: ICO Institut de Cancerologie de l'Ouest, Department of Basic Studies, Faculty of Odontology, University of Antioquia, Institut de Cancérologie de l'Ouest (ICO)-site René Gauducheau, Hephaistos Pharma, Léon Bérard Centre,